港股随A股升幅扩至近200点重越二万八关 手机/电讯/内需股领涨
内地新冠肺炎新增确诊病例2,048宗，累计确诊个案增至70,548宗，死亡人数累增至1,770宗，逾万人康复。人行今天开展2,000亿人民币MLF操作，利率下调10点子至3.15%。此外，人行今天重启逆回购操作金额1,000亿人民币。沪指及深成继上周累弹41点及近2.9%後，今早高开0.3%及0.5%，升幅扩至1.2%及1.7%，分别报2,951及11,101。板块方面，除生物疫苗、流感及医癈处理逆软外，全部造好，逾三分二升幅超过1%-3%；国防军工、通信、海南板块、大飞机及农业种植更依次涨逾4%-5%；但重磅内银及白酒仅升不足0.3%；内房升0.7%。
港股继上周续累升411点或1.5%後，今早低开48点或近0.2%报27,766获承接，掉头高见28,018，创三周新高，现造28,012，倒升197点或0.7%，成交额370亿元。
蓝筹股普遍造好，尤其是吉利汽车(00175.HK)重越100天及50天线(14.51-14.72元)，最高见15.08元，现造14.98元，回升3.5%；蒙牛(02319.HK)、万洲(00192.HK)及旺旺(00151.HK)逾1.5%-2%，後者最强股价重越10天线，最高见6.48元，现造6.45元，续升2%。
两大手机股瑞声(02018.HK)及舜宇(02382.HK)重越10天线，分别报59.3元及133.3元，回升3.2%及2.3%。中移动(00941.HK)及联通(00762.HK)升2%及1.5%，分别报66.4元及6.81元。此外，银娱(00027.HK)及中石化(00386.HK)反覆续升1.7%，分别报58.2元及4.28元。
金融股以友邦(01299.HK)及国寿(02628.HK)表现最好，股价升约1.5%，分别报81.75元及19.58元，前者重越20天及50天线(81.57元)，後者重越10天线(19.42元)。不过，明天放榜的汇控(00005.HK)逆吐0.4%报59.4元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
